vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Four Corners Property Trust, Inc. (FCPT). Click either name above to swap in a different company.

Four Corners Property Trust, Inc. is the larger business by last-quarter revenue ($78.2M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). Four Corners Property Trust, Inc. runs the higher net margin — 38.8% vs -19.9%, a 58.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 9.4%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 8.4%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Four Corners Property Trust, Inc. is a publicly traded real estate investment trust that acquires, owns, and manages a portfolio of high-quality net-leased commercial properties. Its assets are primarily restaurant and retail locations across the United States, with tenants largely operating in stable consumer-facing industry segments with proven operational performance.

ABCL vs FCPT — Head-to-Head

Bigger by revenue
FCPT
FCPT
1.7× larger
FCPT
$78.2M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+779.0% gap
ABCL
788.4%
9.4%
FCPT
Higher net margin
FCPT
FCPT
58.8% more per $
FCPT
38.8%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
8.4%
FCPT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABCL
ABCL
FCPT
FCPT
Revenue
$44.9M
$78.2M
Net Profit
$-8.9M
$30.4M
Gross Margin
Operating Margin
-63.7%
55.3%
Net Margin
-19.9%
38.8%
Revenue YoY
788.4%
9.4%
Net Profit YoY
73.9%
16.0%
EPS (diluted)
$-0.03
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
FCPT
FCPT
Q1 26
$78.2M
Q4 25
$44.9M
$75.7M
Q3 25
$9.0M
$74.1M
Q2 25
$17.1M
$72.8M
Q1 25
$4.2M
$71.5M
Q4 24
$5.0M
$68.3M
Q3 24
$6.5M
$66.8M
Q2 24
$7.3M
$66.5M
Net Profit
ABCL
ABCL
FCPT
FCPT
Q1 26
$30.4M
Q4 25
$-8.9M
$29.4M
Q3 25
$-57.1M
$28.8M
Q2 25
$-34.7M
$27.9M
Q1 25
$-45.6M
$26.2M
Q4 24
$26.2M
Q3 24
$-51.1M
$25.6M
Q2 24
$-36.9M
$24.7M
Operating Margin
ABCL
ABCL
FCPT
FCPT
Q1 26
55.3%
Q4 25
-63.7%
Q3 25
-851.8%
Q2 25
-290.2%
Q1 25
-1479.6%
Q4 24
Q3 24
-1439.4%
Q2 24
-1276.2%
Net Margin
ABCL
ABCL
FCPT
FCPT
Q1 26
38.8%
Q4 25
-19.9%
38.9%
Q3 25
-637.8%
38.9%
Q2 25
-203.3%
38.3%
Q1 25
-1077.2%
36.6%
Q4 24
38.3%
Q3 24
-785.4%
38.3%
Q2 24
-504.3%
37.1%
EPS (diluted)
ABCL
ABCL
FCPT
FCPT
Q1 26
$0.28
Q4 25
$-0.03
$0.27
Q3 25
$-0.19
$0.28
Q2 25
$-0.12
$0.28
Q1 25
$-0.15
$0.26
Q4 24
$0.27
Q3 24
$-0.17
$0.27
Q2 24
$-0.13
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
FCPT
FCPT
Cash + ST InvestmentsLiquidity on hand
$128.5M
$29.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$1.7B
Total Assets
$1.4B
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
FCPT
FCPT
Q1 26
$29.6M
Q4 25
$128.5M
$12.1M
Q3 25
$83.2M
$6.7M
Q2 25
$92.4M
$6.0M
Q1 25
$159.3M
$22.3M
Q4 24
$156.3M
$4.1M
Q3 24
$126.6M
$44.5M
Q2 24
$148.3M
$17.2M
Total Debt
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.2B
Stockholders' Equity
ABCL
ABCL
FCPT
FCPT
Q1 26
$1.7B
Q4 25
$966.9M
$1.6B
Q3 25
$964.0M
$1.5B
Q2 25
$1.0B
$1.5B
Q1 25
$1.0B
$1.4B
Q4 24
$1.1B
$1.5B
Q3 24
$1.1B
$1.4B
Q2 24
$1.1B
$1.3B
Total Assets
ABCL
ABCL
FCPT
FCPT
Q1 26
$3.0B
Q4 25
$1.4B
$2.9B
Q3 25
$1.4B
$2.8B
Q2 25
$1.4B
$2.8B
Q1 25
$1.3B
$2.7B
Q4 24
$1.4B
$2.7B
Q3 24
$1.4B
$2.6B
Q2 24
$1.4B
$2.5B
Debt / Equity
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
0.74×
Q3 25
0.79×
Q2 25
0.81×
Q1 25
0.84×
Q4 24
0.78×
Q3 24
0.84×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
FCPT
FCPT
Operating Cash FlowLast quarter
$-34.7M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
$-34.7M
$192.3M
Q3 25
$-52.6M
$48.9M
Q2 25
$-32.4M
$43.8M
Q1 25
$-11.6M
$51.6M
Q4 24
$-108.6M
$144.1M
Q3 24
$-28.9M
$43.4M
Q2 24
$-30.0M
$39.7M
Free Cash Flow
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
$-44.6M
Q3 25
$-61.5M
Q2 25
$-45.8M
Q1 25
$-22.2M
Q4 24
$-187.0M
Q3 24
$-47.4M
Q2 24
$-50.1M
FCF Margin
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
-99.4%
Q3 25
-687.0%
Q2 25
-267.9%
Q1 25
-524.0%
Q4 24
-3702.8%
Q3 24
-728.4%
Q2 24
-683.8%
Capex Intensity
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
21.9%
Q3 25
99.7%
Q2 25
78.2%
Q1 25
251.1%
Q4 24
1552.7%
Q3 24
284.6%
Q2 24
274.6%
Cash Conversion
ABCL
ABCL
FCPT
FCPT
Q1 26
Q4 25
6.53×
Q3 25
1.70×
Q2 25
1.57×
Q1 25
1.97×
Q4 24
5.51×
Q3 24
1.70×
Q2 24
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

FCPT
FCPT

Rental revenue$69.8M89%
Restaurant revenue$8.4M11%

Related Comparisons